to assess flecainide 's ability to suppress ventricular fibrillation during reperfusion , we compared flecainide acetate ( 2 mg/kg i.v . ) with saline placebo in 50 pentobarbital-anesthetized dogs undergoing proximal anterior descending coronary artery occlusion for 20 min followed by sudden release .
C0016229
flecainide 's
C0086303
flecainide acetate